Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rh disease: how near the end?

V J Freda, W Pollack, J G Gorman

    Hospital Practice
    |June 1, 1978
    PubMed
    Summary

    Routine postpartum administration of Rh immune globulin has made hemolytic disease of newborns preventable. Adhering to guidelines ensures all susceptible Rh-negative mothers receive treatment, aiming for disease elimination within a decade.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Crossmatching with rh immune globulin.

    Canadian Medical Association journal·2010
    Same author

    HTLV-I provirus in seronegative healthy blood donors.

    Lancet (London, England)·1997
    Same author

    Quantitative evaluation of renal excretion on the dynamic DTPA renal scan.

    Clinical nuclear medicine·1989
    Same author

    HTLV-III antibody in commercial immunoglobulin.

    Lancet (London, England)·1986
    Same author

    A physico-chemical study of PVP-I solutions leading to the reformulation of 'Betadine' preparations (5% PVP-I).

    The Journal of hospital infection·1985
    Same author

    In vitro studies of the killing of clinical isolates by povidone-iodine solutions.

    The Journal of hospital infection·1985

    Area of Science:

    • Obstetrics and Gynecology
    • Neonatal Medicine
    • Immunology

    Background:

    • Hemolytic disease of newborns (HDN) poses a significant risk to infants.
    • Rh immune globulin (RhIG) administration has been a key intervention.
    • The postpartum administration of RhIG has been implemented for a decade.

    Purpose of the Study:

    • To evaluate the impact of routine postpartum Rh immune globulin administration on preventing hemolytic disease of newborns.
    • To emphasize the importance of adhering to clinical and administrative guidelines for RhIG treatment.
    • To project the potential for complete elimination of HDN with continued adherence to protocols.

    Main Methods:

    • Retrospective analysis of HDN incidence.
    • Review of clinical and administrative guidelines for RhIG administration.
    • Assessment of treatment adherence among Rh-negative mothers.

    Main Results:

    • Hemolytic disease of newborns is now a preventable condition.
    • The introduction of routine postpartum RhIG administration has been effective over the past 10 years.
    • Careful adherence to guidelines is crucial for maximizing treatment success.

    Conclusions:

    • Routine postpartum RhIG administration has successfully transformed HDN from a prevalent to a preventable disease.
    • Continued vigilance and adherence to established guidelines are essential for the complete eradication of HDN.
    • The elimination of HDN is achievable within the next decade with consistent application of preventive strategies.

    Related Experiment Videos